Literature DB >> 14583299

Pulmonary resection for massive hemoptysis of benign etiology.

Adel Ayed1.   

Abstract

OBJECTIVE: To assess the outcome of pulmonary resection in the management of massive hemoptysis caused by benign lung diseases.
METHODS: A longitudinal cohort study of 53 consecutive patients who presented with hemoptysis and were treated with either emergency (group 1) or elective (group 2) pulmonary resection from January 1995 to December 1999.
RESULTS: Fifty-three patients were studied, 27 in group 1 and 26 in group 2. The mean age of the patients was 47.2 years (range, 29-70 years). Urgent examination with a combination of rigid and flexible fiberoptic bronchoscope localized the bleeding site in 45 patients (85%). Age>50 years, hypertension, hemoglobin on admission<10 g/dl, cause of hemoptysis, and a prior attack of hemoptysis were the predictors for the need of emergency surgery. The overall hospital mortality rate was 4% (2/53). Postoperative complications occurred in 13 patients (25%). Complications were more common in patients who received blood transfusion than non-transfused patients (9/23 and 4/30, respectively; P=0.03). Patients with tuberculosis as the cause of massive hemoptysis had more complications 5/8 in comparison to all other patients (P=0.02). The mean follow-up was 4.5 years (range, 3-6 years) for all patients who survived. Hemoptysis recurred in four patients (8%) and all from group 1 (P=0.02).
CONCLUSIONS: Immediate pulmonary resection for massive hemoptysis is effective in case of life-threatening bleeding that is not controlled by conservative measures. Elderly patients with a prior history of hemoptysis and/or hypertension and bleeding due to a fungus ball, necrotizing pneumonia, tuberculosis or lung abscess should be considered for early operation in an attempt to reduce morbidity and mortality.

Entities:  

Mesh:

Year:  2003        PMID: 14583299     DOI: 10.1016/s1010-7940(03)00508-6

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  9 in total

1.  Management of Massive Hemoptysis: Analyses of 58 Patients.

Authors:  Alkın Yazıcıoğlu; Erdal Yekeler; Ülkü Yazıcı; Ertan Aydın; İrfan Taştepe; Nurettin Karaoğlanoğlu
Journal:  Turk Thorac J       Date:  2016-10-01

Review 2.  The Diagnosis and Treatment of Hemoptysis.

Authors:  Harald Ittrich; Maximilian Bockhorn; Hans Klose; Marcel Simon
Journal:  Dtsch Arztebl Int       Date:  2017-06-05       Impact factor: 5.594

3.  [Hemoptysis].

Authors:  L Freitag; H N Macha
Journal:  Internist (Berl)       Date:  2004-05       Impact factor: 0.743

Review 4.  Thoracic surgery for haemoptysis in the context of tuberculosis: what is the best management approach?

Authors:  Semih Halezeroğlu; Erdal Okur
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

5.  Severe Hemoptysis Associated with Bacterial Pulmonary Infection: Clinical Features, Significance of Parenchymal Necrosis, and Outcome.

Authors:  Guillaume Carteaux; Damien Contou; Guillaume Voiriot; Antoine Khalil; Marie-France Carette; Martine Antoine; Antoine Parrot; Muriel Fartoukh
Journal:  Lung       Date:  2017-10-12       Impact factor: 2.584

6.  Surgery for hemoptysis in patients with benign lung disease.

Authors:  Ju Sik Yun; Sang Yun Song; Kook Joo Na; Seok Kim; Keun-Ho Jang; In Seok Jeong; Sang Gi Oh
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

7.  Analysis of patients with hemoptysis in a tertiary referral hospital.

Authors:  Bo Ram Lee; Jin Yeong Yu; Hee Jung Ban; In Jae Oh; Kyu Sik Kim; Yong Soo Kwon; Yu Il Kim; Young Chul Kim; Sung Chul Lim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-08-31

8.  Emergency pulmonary resection in massive hemoptysis: analysis of 39 patients.

Authors:  Serkan Yazgan; Ahmet Ucvet; Kenan Can Ceylan; Canberk Heskiloglu; Banu Yoldas; Serpil Sevinc
Journal:  Kardiochir Torakochirurgia Pol       Date:  2022-01-09

9.  Characteristics and Treatment Outcomes of Patients with Tuberculosis Receiving Adjunctive Surgery in Uzbekistan.

Authors:  Anvar Riskiyev; Ana Ciobanu; Arax Hovhannesyan; Kristina Akopyan; Jamshid Gadoev; Nargiza Parpieva
Journal:  Int J Environ Res Public Health       Date:  2021-06-17       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.